News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search The EXPOSIM project to transform the understanding of the environmental impact on health 09/01/2025 Dr. Marc Miravitlles, new vice president of the ERS and future president (2026-2027) 17/09/2024 Dr. Eva Polverino receives the ERS Teaching Award 05/09/2024 Dr Marc Miravitlles named honorary member of SEPAR 10/06/2024 Dr. Rafael Simó receives the Eva Kohner Award for his career in research 15/06/2023 D-Sight, a Vall d’Hebron spin-off, raises €1M to develop a new drug 02/05/2023 The Spanish Diabetes Society awards the career of Dr. Rafael Simó 21/04/2023 Demonstrated the safety of therapy with viruses to combat multidrug-resistant bacteria 13/04/2023 3 projects recognized at Congress of Pediatric Gastroenterology, Hepatology and Nutrition 31/08/2022 Vall d'Hebron hosts a meeting of the EXIMIOUS project 23/05/2022 A study participated by Vall d'Hebron approves a treatment for severe pediatric asthma 02/05/2022 A Vall d’Hebron study relates the impact of obesity to cognitive impairment 26/01/2022 Vall d'Hebron identifies that patients with diabetes and myocardial insulin resistance have high cardiovascular risk 24/01/2022 Vall d'Hebron participates in an international study that evaluated a drug that will improve the treatment of cystic fibrosis 01/12/2021 Vall d’Hebron and IDIAP Jordi Gol join forces to research cardiovascular diseases and diabetes 30/11/2021 A Vall d'Hebron study allows optimizing the treatment of patients with severe damage in their lungs after COVID-19 18/11/2021 Two Vall d’Hebron professionals are ambassadors of the ERS International Congress, the world's most important congress on respiratory diseases 05/09/2021 Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards 27/06/2021 Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat 16/06/2021 Asthma could protect against COVID-19 in a specific group of asthmatic patients 23/11/2020 Pagination 1 2 Next › Next page Last » Last page